James Renwick McCullough

Insider Reports History

Location
London, United Kingdom
Signature
/s/ Katie Kazem, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Renwick McCullough:

Company Role Class Num Shares Value Price $ Report Date Ownership
Renalytix plc Chief Executive Officer, Director Ordinary Shares 2,554,398 $638,600 $0.25 01 Jul 2023 By The McCullough 2020 Irrevocable Trust
Renalytix plc Chief Executive Officer, Director Ordinary Shares 191,988 $47,997 $0.25 01 Jul 2023 Direct
Renalytix plc Chief Executive Officer, Director Employee Stock Option (right to buy) 875,017 06 Jul 2023 Direct

Insider Reports Filed by James Renwick McCullough

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNLX Renalytix plc 06 Jul 2023 1 $0 4 Chief Executive Officer, Director 07 Jul 2023, 16:27
RNLX Renalytix plc 01 Jul 2023 0 $0 3 Chief Executive Officer, Director 03 Jul 2023, 16:21